Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Alghamri, Mahmoud S., McClellan, Brandon L., Hartlage, Carson S., Haase, Santiago, Faisal, Syed Mohd, Thalla, Rohit, Dabaja, Ali, Banerjee, Kaushik, Carney, Stephen V., Mujeeb, Anzar A., Olin, Michael R., Moon, James J., Schwendeman, Anna, Lowenstein, Pedro R., Castro, Maria G.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167057/
https://ncbi.nlm.nih.gov/pubmed/34084145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.680021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados